The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
The Issuer is in the business of cannabis cultivation, production and dispensaries. The Issuer also has a patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency.
Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.
CordovaCann Corp. is a Canadian-domiciled cannabis-focused consumer products company. CordovaCann primarily provides services and investment capital to the processing and production vertical markets of the cannabis industry.
Cresco Labs, based in Chicago is a grower, processor and retailer of premium cannabis with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states (New York, Massachusetts, Maryland). The company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry. Its speed-to-market gives Cresco a competitive advantage as it replicates its model to expand its national footprint. Cresco’s ability to execute is complemented by a brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
(Note: In addition to the 21,873,969 Subordinate Voting Shares that are listed and trading, there are 270,070,803 Subordinate Voting Shares reserved for issuance pursuant to pending acquisitions, the redemption and conversion rights attached to: (i) the Proportionate Voting Shares of Cresco Labs Inc.; and (ii) certain outstanding securities of Cresco Labs, LLC, which is a subsidiary of Cresco Labs, Inc. The total number of Subordinate Voting Shares as converted is 294,567,873, inclusive of options, options reserved for issuance and warrants.)
Curaleaf Holdings, Inc., its subsidiaries and managed entities are directly engaged in the manufacture, possession, use, sale or distribution of cannabis and/or hold licenses in the adult-use and/or medicinal cannabis marketplace in the States of Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon.
Investor Note: In addition to the 338,609,444 Subordinate Voting Shares that are listed and trading, there are 122,170,705 shares reserved specifically for issuance pursuant to the conversion rights attached to the Multiple Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all Multiple Voting Shares are converted into the listed class would be 460,780,149.
DionyMed is a multi-state, vertically integrated operating platform that designs, develops, markets and sells a portfolio of branded cannabis products. DionyMed also provides distribution, logistics and value-added manufacturing services on behalf of cannabis cultivators, distributors, processors and retailers. DionyMed’s operations are currently located in California and Oregon.
Investor Note: In addition to the 25,719,083 Subordinate Voting Shares that are listed and trading, there are 32,553,400 Subordinate Voting Shares reserved for issuance pursuant to the conversion rights attached to other classes of equity shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 58,272,483.
Dixie Brands Inc. manages, protects and promotes a portfolio of licensed intellectual property and commercialization of proprietary processes and products related to the DIXIETM brand. Dixie Brands Inc. is actively engaged in the licensing of proprietary bases, essences, and other prepared ingredients, the formula of which is an industrial secret of Dixie Brands Inc.
Eviana Health Corporation’s aim is to deliver customized consumer skin care products using natural hemp strains of cannabis sativa for cosmeceutical and nutraceutical merchandise and cannabinoid-based topical creams and products.
EXMceuticals Inc. (“EXM”) is a cannabis wholesale company with a head office in Vancouver, British Columbia and operations in the Democratic Republic of Congo, Malawi, Portugal and Uganda. EXM also has an experienced international team that has a deep working-knowledge of agriculture and Africa. EXM’s activities are focused on the sustainable cultivation of cannabis and hemp, and the production of pharmaceutical grade, psychotropic and non-psychotropic cannabis and hemp ingredients for the pharmaceutical, therapeutical and nutraceutical industries. The company aims to offer the most secure supply chain of cannabinoid ingredients that exists in industry and export the extracted ingredients to international markets. In addition, the company wishes to enhance living conditions locally through its buy local, hire local policy and through local foundations. EXM is in the process of obtaining additional licenses and establishing operations across multiple sites in Africa, including Ethiopia, Zambia and Burundi. In addition, EXM is in the process of obtaining a license in Portugal for the establishment of a research laboratory, a nursery, and a center for processing and distribution. EXM uses the Supercritical CO2 method for extraction – a chemical-free process that offers high molecule separation strength. By using this method, EXM will provide to customers a pure, natural product of superior quality. EXM can rely on important R&D and distribution partners to complete their expertise.
Advertisement
Publicité
Advertisement
Publicité
